Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies by Margaux Lejeune, Murat Cem Köse, Elodie Duray, Hermann Einsele, Yves Beguin, Yves Beguin, Jo Caers, Jo Caers

Get full text

Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents? by Monika Engelhardt, Gabriele Ihorst, Jo Caers, Andreas Günther, Ralph Wäsch

Get full text

The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma by Jo Caers, Nadia Withofs, Jens Hillengass, Paolo Simoni, Elena Zamagni, Roland Hustinx, Yves Beguin

Get full text

Radiotheranostic Agents in Hematological Malignancies by Jo Caers, Jo Caers, Elodie Duray, Elodie Duray, Louise Vrancken, Louise Vrancken, Guillaume Marcion, Valentina Bocuzzi, Kim De Veirman, Ahmet Krasniqi, Margaux Lejeune, Nadia Withofs, Nick Devoogdt, Mireille Dumoulin, Amelie Eriksson Karlström, Matthias D’Huyvetter

Get full text

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents by Arnold Bolomsky, Meike Vogler, Murat Cem Köse, Caroline A. Heckman, Grégory Ehx, Heinz Ludwig, Jo Caers

Get full text

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents by Arnold Bolomsky, Meike Vogler, Murat Cem Köse, Caroline A. Heckman, Grégory Ehx, Heinz Ludwig, Jo Caers

Get full text

The Effects of Forodesine in Murine and Human Multiple Myeloma Cells by Liesbeth Bieghs, Jo Caers, Elke De Bruyne, Els Van Valckenborgh, Fiona Higginbotham, Karin Vanderkerken, Eline Menu

Get full text

CD38 as theranostic target in oncology by Valentina Bocuzzi, Jessica Bridoux, Michelle Pirotte, Nadia Withofs, Roland Hustinx, Matthias D’Huyvetter, Jo Caers, Guillaume Marcion

Get full text

Correction to: CD38 as theranostic target in oncology by Valentina Bocuzzi, Jessica Bridoux, Michelle Pirotte, Nadia Withofs, Roland Hustinx, Matthias D’Huyvetter, Jo Caers, Guillaume Marcion

Get full text

Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factors. by Eléonore Otjacques, Marilène Binsfeld, Natacha Rocks, Silvia Blacher, Karin Vanderkerken, Agnès Noel, Yves Beguin, Didier Cataldo, Jo Caers

Get full text

Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma by Arnold Bolomsky, Roy Heusschen, Karin Schlangen, Kathrin Stangelberger, Joséphine Muller, Wolfgang Schreiner, Niklas Zojer, Jo Caers, Heinz Ludwig

Get full text

Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel by Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina N. Badelita

Get full text

Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. by Marilène Binsfeld, Yves Beguin, Ludovic Belle, Eléonore Otjacques, Muriel Hannon, Alexandra Briquet, Roy Heusschen, Pierre Drion, Jenny Zilberberg, Bjarne Bogen, Frédéric Baron, Jo Caers

Get full text

Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma by Silvano Marchiori, François Cousin, Iraklis Papadopoulos, Claire Bernard, Marie Thys, Bernard De Prijck, Michelle Pirotte, Anne-Françoise Donneau, Roland Hustinx, Jo Caers, Nadia Withofs

Get full text

A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma by Elodie Duray, Margaux Lejeune, Frederic Baron, Yves Beguin, Nick Devoogdt, Ahmet Krasniqi, Yoline Lauwers, Yong Juan Zhao, Matthias D’Huyvetter, Mireille Dumoulin, Jo Caers

Get full text

Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells by Caroline Ritacco, Murat Cem Köse, Justine Courtois, Lorenzo Canti, Charline Beguin, Sophie Dubois, Benoît Vandenhove, Sophie Servais, Jo Caers, Yves Beguin, Grégory Ehx, Frédéric Baron

Get full text

A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease. by Peter O Hofgaard, Henriette C Jodal, Kurt Bommert, Bertrand Huard, Jo Caers, Harald Carlsen, Rolf Schwarzer, Nicole Schünemann, Franziska Jundt, Mona M Lindeberg, Bjarne Bogen

Get full text

Extramedullary disease in multiple myeloma: a systematic literature review by Joan Bladé, Meral Beksac, Jo Caers, Artur Jurczyszyn, Marie von Lilienfeld-Toal, Philippe Moreau, Leo Rasche, Laura Rosiñol, Saad Z. Usmani, Elena Zamagni, Paul Richardson

Get full text

Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient? by David Kegyes, Catalin Constantinescu, Louise Vrancken, Leo Rasche, Celine Gregoire, Bogdan Tigu, Diana Gulei, Delia Dima, Alina Tanase, Hermann Einsele, Stefan Ciurea, Ciprian Tomuleasa, Jo Caers

Get full text

Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma by Jo Caers, Dirk Hose, Ine Kuipers, Tomas Jan Bos, Els Van Valckenborgh, Eline Menu, Elke De Bruyne, Hartmut Goldschmidt, Ben Van Camp, Bernard Klein, Karin Vanderkerken

Get full text